Children's Hospital of Fudan University
Children's Hospital of Fudan University
Shanghai, China10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Abnormalities, Digestive System Diseases, bile duct disorder, biliary atresia, biliary tract disorder | Active, not recruiting | Phase 3 | 2026-10-01 | NCT05426733 | |
| Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Tumor Virus Infections, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Recruiting | Phase 2 / Phase 3 | 2026-07-23 | NCT06764238 | |
| Effects of Intermittent Dietary Restriction on Cardiometabolic Risk in School-aged Children | Insulin Resistance, Nutritional and Metabolic Diseases, glucose metabolism disease, hyperinsulinism, metabolic disease, metabolic syndrome X | Recruiting | Not applicable | 2026-07-06 | NCT06500078 | |
| Close Loop Smart Weaning for INO With PPHN | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, lung disorder, persistent fetal circulation syndrome, pulmonary hypertension, respiratory system disorder | Recruiting | Not applicable | 2026-05-13 | NCT06832163 | |
| Development of Prosocial Behaviors and Related Brain Network in Infants of High and Low Risk of ASD | autism, autism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Recruiting | Not stated | 2026-03-16 | NCT06329245 | |
| YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases | Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, diffuse scleroderma, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, vascular disorder, vasculitis | Not yet recruiting | Phase 1 | 2026-02-27 | NCT07439029 | |
| Differences in Prosocial Behaviors and Related Brain Networks in Children With Autism and Typical Development | autism, autism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Recruiting | Not stated | 2025-05-29 | NCT06908174 | |
| Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura | Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, blood coagulation disease, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not applicable | 2025-02-19 | NCT03647852 | |
| Clinical Cohort Study of DHA in Neurodevelopmental Disorders | autism, autism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2025-02-18 | NCT05841927 | |
| Evaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry Disease | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fabry disease, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, X-linked disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hereditary disease, inborn errors of metabolism, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, sphingolipidosis, vascular disorder | Recruiting | Early phase 1 | 2024-07-09 | NCT06207552 |